Initial investigation into the optimal dose ratio of conjugated estrogens and bazedoxifene: a double-blind, randomized, placebo-controlled phase 2 dose-finding study

Menopause : the Journal of the North American Menopause Society
James H PickarBarry S Komm

Abstract

The aim of the study was to explore dose-related endometrial effects of conjugated estrogens/bazedoxifene (CE/BZA). In this randomized, double-blind, phase 2 study, 408 nonhysterectomized, symptomatic (with hot flushes [HFs]) postmenopausal women received ≥1 dose of CE 0.3 or 0.625 mg alone or with BZA 5, 10, or 20 mg/d; placebo; BZA 5 mg/d alone; or CE 0.625 mg with medroxyprogesterone acetate 2.5 mg/d for 84 days. The primary outcome was endometrial thickness on transvaginal ultrasound. HF frequency and severity based on diaries were key secondary outcomes. CE 0.625 mg alone increased endometrial thickness compared with placebo (mean 5.5 vs 2.95 mm, P < 0.001); BZA countered this in a dose-related manner such that average thickness with the addition of BZA 5, 10, and 20 mg was 5.99, 4.33, and 3.54 mm, respectively. On average, endometrium was significantly less thick with CE 0.625 mg/BZA 20 mg than CE 0.625 mg (P < 0.001) and CE 0.3 mg/BZA 20 mg versus CE 0.3 mg (2.94 vs 3.92 mm, P < 0.05); endometrial thickness was similar to placebo with CE 0.625 mg/BZA 20 mg. Lower BZA doses failed to reduce endometrial thickness relative to the same dose of CE alone. Regimens containing CE 0.625 mg reduced HF frequency and severity versus...Continue Reading

References

Jun 1, 1997·Regulatory Toxicology and Pharmacology : RTP·J AshbyJ R Foster
Jan 10, 1998·American Journal of Obstetrics and Gynecology·S M BossM W Draper
Mar 17, 2004·Menopause : the Journal of the North American Menopause Society·Susan R DavisDaniel Thiebaud
Feb 23, 2007·Menopause : the Journal of the North American Menopause Society·Dale W StovallLeo Plouffe
Jun 24, 2009·Menopause : the Journal of the North American Menopause Society·JoAnn V PinkertonJames H Pickar
Jul 29, 2009·Fertility and Sterility·David F ArcherJames H Pickar
Oct 30, 2009·Climacteric : the Journal of the International Menopause Society·G BachmannS Mirkin
Mar 1, 2012·Menopause : the Journal of the North American Menopause Society·UNKNOWN North American Menopause Society
May 3, 2012·Menopause : the Journal of the North American Menopause Society·Andrea Lucia Bastos CarneiroMauro Abi Haidar
Oct 9, 2012·Climacteric : the Journal of the International Menopause Society·S MirkinA A Chines
Oct 30, 2012·Menopause : the Journal of the North American Menopause Society·Kelly F EthunThomas B Clarkson
Dec 29, 2012·Menopause : the Journal of the North American Menopause Society·Jennifer A HarveySebastian Mirkin
Mar 29, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Suzanne E WardellDonald P McDonnell
May 3, 2013·Obstetrics and Gynecology·JoAnn V PinkertonSebastian Mirkin
Jun 26, 2013·Menopause : the Journal of the North American Menopause Society·Kelly F EthunThomas B Clarkson
Aug 15, 2013·Menopause : the Journal of the North American Menopause Society·Joann V PinkertonSebastian Mirkin
Jan 21, 2014·The Journal of Clinical Endocrinology and Metabolism·Joann V PinkertonUNKNOWN SMART-5 Investigators
Sep 17, 2014·Menopause : the Journal of the North American Menopause Society·Jan L ShifrenUNKNOWN NAMS Recommendations for Clinical Care of Midlife Women Working Group
Apr 9, 2016·Journal of Women's Health·Sebastian MirkinDavid F Archer

❮ Previous
Next ❯

Citations

Mar 14, 2018·Menopause : the Journal of the North American Menopause Society·James H PickarDiana Morgenstern

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.